Is Enanta Pharmaceuticals, Inc. (ENTA) a Buy, Sell, or Hold?
NASDAQ : ENTA
Enanta Pharmaceuticals, Inc.
$13.74 USD
$0.55 (4.17%)
- Volume
- 182.04K
- Average Volume
- 212.6K
- Market Capitalization
- $319M
- P/E Ratio
- -5.01
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $17.15
- Year Low
- $6.45
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.84
Insider Activity Summary (Last 12 Months)
Insiders Buying
41
Insiders Selling
28
Amount of Insider Selling
$65223
ENTA Insider Buying/Selling by Quarter
ENTA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Vance Terry | director | 2026-03-11 | A-Award | 14.17 | 2026-03-13 |
| Russell Lesley | director | 2026-03-11 | A-Award | 14.17 | 2026-03-13 |
| Peterson Kristine | director | 2026-03-11 | A-Award | 14.17 | 2026-03-13 |
| Hata Yujiro S | director | 2026-03-11 | A-Award | 14.17 | 2026-03-13 |
| FOLETTA MARK G | director | 2026-03-11 | A-Award | 14.17 | 2026-03-13 |
| CARTER BRUCE L A | director | 2026-03-11 | A-Award | 14.17 | 2026-03-13 |
| Kowalsky Matthew Paul | officer: Chief Legal Officer | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Kowalsky Matthew Paul | officer: Chief Legal Officer | 2026-02-12 | F-InKind | 14.25 | 2026-02-13 |
| Kowalsky Matthew Paul | officer: Chief Legal Officer | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Luu Brendan | officer: Chief Business Officer | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Luu Brendan | officer: Chief Business Officer | 2026-02-12 | F-InKind | 14.25 | 2026-02-13 |
| Luu Brendan | officer: Chief Business Officer | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Kieffer Tara Lynn | officer: Chief Product Strategy Officer | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Kieffer Tara Lynn | officer: Chief Product Strategy Officer | 2026-02-12 | F-InKind | 14.25 | 2026-02-13 |
| Kieffer Tara Lynn | officer: Chief Product Strategy Officer | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Rottinghaus Scott T. | officer: Chief Medical Officer | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Rottinghaus Scott T. | officer: Chief Medical Officer | 2026-02-12 | F-InKind | 14.25 | 2026-02-13 |
| Rottinghaus Scott T. | officer: Chief Medical Officer | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Or Yat Sun | officer: Chief Scientific Officer | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Or Yat Sun | officer: Chief Scientific Officer | 2026-02-12 | F-InKind | 14.25 | 2026-02-13 |
| Or Yat Sun | officer: Chief Scientific Officer | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Luly Jay R. | director, officer: President and CEO | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Luly Jay R. | director, officer: President and CEO | 2026-02-12 | F-InKind | 14.25 | 2026-02-13 |
| Luly Jay R. | director, officer: President and CEO | 2026-02-12 | A-Award | 0 | 2026-02-13 |
| Capps Kathleen S. | officer: See Remarks | 2025-12-05 | S-Sale | 14.23 | 2025-12-05 |
| Trout Harry R. III | officer: See Remarks | 2025-12-05 | S-Sale | 14.23 | 2025-12-05 |
| Rottinghaus Scott T. | officer: Chief Medical Officer | 2025-12-05 | S-Sale | 14.23 | 2025-12-05 |
| Luu Brendan | officer: Chief Business Officer | 2025-12-05 | S-Sale | 14.23 | 2025-12-05 |
| Kieffer Tara Lynn | officer: Chief Product Strategy Officer | 2025-12-05 | S-Sale | 14.23 | 2025-12-05 |
| Or Yat Sun | officer: Chief Scientific Officer | 2025-12-05 | S-Sale | 14.23 | 2025-12-05 |
| Luly Jay R. | director, officer: President and CEO | 2025-12-05 | S-Sale | 14.23 | 2025-12-05 |
| Capps Kathleen S. | officer: See Remarks | 2025-12-01 | F-InKind | 14.12 | 2025-12-03 |
| Capps Kathleen S. | officer: See Remarks | 2025-12-02 | S-Sale | 13.96 | 2025-12-03 |
| Trout Harry R. III | officer: See Remarks | 2025-12-01 | F-InKind | 14.12 | 2025-12-03 |
| Trout Harry R. III | officer: See Remarks | 2025-12-02 | S-Sale | 13.96 | 2025-12-03 |
| Luu Brendan | officer: Chief Business Officer | 2025-12-01 | F-InKind | 14.12 | 2025-12-03 |
| Kieffer Tara Lynn | officer: Chief Product Strategy Officer | 2025-12-01 | F-InKind | 14.12 | 2025-12-03 |
| Or Yat Sun | officer: Chief Scientific Officer | 2025-12-01 | F-InKind | 14.12 | 2025-12-03 |
| Luly Jay R. | director, officer: President and CEO | 2025-12-01 | F-InKind | 14.12 | 2025-12-03 |
| Capps Kathleen S. | officer: See Remarks | 2025-11-25 | A-Award | 0 | 2025-11-26 |
| Capps Kathleen S. | officer: See Remarks | 2025-11-25 | A-Award | 13.66 | 2025-11-26 |
| Trout Harry R. III | officer: See Remarks | 2025-11-25 | A-Award | 0 | 2025-11-26 |
| Trout Harry R. III | officer: See Remarks | 2025-11-25 | A-Award | 13.66 | 2025-11-26 |
| Luu Brendan | officer: Chief Business Officer | 2025-11-25 | A-Award | 13.66 | 2025-11-26 |
| Kieffer Tara Lynn | officer: Chief Product Strategy Officer | 2025-11-25 | A-Award | 13.66 | 2025-11-26 |
| Kowalsky Matthew Paul | officer: Chief Legal Officer | 2025-11-25 | A-Award | 13.66 | 2025-11-26 |
| Rottinghaus Scott T. | officer: Chief Medical Officer | 2025-11-25 | A-Award | 13.66 | 2025-11-26 |
| Or Yat Sun | officer: Chief Scientific Officer | 2025-11-25 | A-Award | 13.66 | 2025-11-26 |
| Luly Jay R. | director, officer: President and CEO | 2025-11-25 | A-Award | 13.66 | 2025-11-26 |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 0 | 2025-09-08 | |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 48.52 | 2025-09-08 | |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 43.57 | 2025-09-08 | |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 45 | 2025-09-08 | |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 8.99 | 2025-09-08 | |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 8.83 | 2025-09-08 | |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 29.68 | 2025-09-08 | |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 81.2 | 2025-09-08 | |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 75.33 | 2025-09-08 | |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 30 | 2025-09-08 | |
| Capps Kathleen S. | officer: See Remarks | 2025-08-26 | 63.35 | 2025-09-08 | |
| Trout Harry R. III | officer: Vice President, Finance | 2025-08-26 | 0 | 2025-09-08 | |
| Trout Harry R. III | officer: Vice President, Finance | 2025-08-26 | 81.2 | 2025-09-08 | |
| Trout Harry R. III | officer: Vice President, Finance | 2025-08-26 | 75.33 | 2025-09-08 | |
| Trout Harry R. III | officer: Vice President, Finance | 2025-08-26 | 45 | 2025-09-08 | |
| Trout Harry R. III | officer: Vice President, Finance | 2025-08-26 | 43.57 | 2025-09-08 | |
| Trout Harry R. III | officer: Vice President, Finance | 2025-08-26 | 8.99 | 2025-09-08 | |
| Trout Harry R. III | officer: Vice President, Finance | 2025-08-26 | 8.83 | 2025-09-08 | |
| Trout Harry R. III | officer: Vice President, Finance | 2025-08-26 | 63.35 | 2025-09-08 | |
| Rottinghaus Scott T. | officer: Chief Medical Officer | 2025-08-08 | F-InKind | 6.99 | 2025-08-08 |
| Vance Terry | director | 2025-03-13 | A-Award | 6.83 | 2025-03-14 |
| Russell Lesley | director | 2025-03-13 | A-Award | 6.83 | 2025-03-14 |
| Peterson Kristine | director | 2025-03-13 | A-Award | 6.83 | 2025-03-14 |
| Hata Yujiro S | director | 2025-03-13 | A-Award | 6.83 | 2025-03-14 |
| FOLETTA MARK G | director | 2025-03-13 | A-Award | 6.83 | 2025-03-14 |
| CARTER BRUCE L A | director | 2025-03-13 | A-Award | 6.83 | 2025-03-14 |
| Luu Brendan | officer: Chief Business Officer | 2025-02-12 | A-Award | 0 | 2025-02-14 |
| Luu Brendan | officer: Chief Business Officer | 2025-02-12 | F-InKind | 5.59 | 2025-02-14 |
| Kieffer Tara Lynn | officer: Chief Product Strategy Officer | 2025-02-12 | A-Award | 0 | 2025-02-14 |
| Kieffer Tara Lynn | officer: Chief Product Strategy Officer | 2025-02-12 | F-InKind | 5.59 | 2025-02-14 |
| Rottinghaus Scott T. | officer: Chief Medical Officer | 2025-02-12 | A-Award | 0 | 2025-02-14 |
| Rottinghaus Scott T. | officer: Chief Medical Officer | 2025-02-12 | F-InKind | 5.59 | 2025-02-14 |
| Or Yat Sun | officer: Chief Scientific Officer | 2025-02-12 | A-Award | 0 | 2025-02-14 |
| Or Yat Sun | officer: Chief Scientific Officer | 2025-02-12 | F-InKind | 5.59 | 2025-02-14 |
| MELLETT PAUL J | officer: Chief Fin. & Admin Officer | 2025-02-12 | A-Award | 0 | 2025-02-14 |
| MELLETT PAUL J | officer: Chief Fin. & Admin Officer | 2025-02-12 | F-InKind | 5.59 | 2025-02-14 |
| Luly Jay R. | director, officer: President and CEO | 2025-02-12 | A-Award | 0 | 2025-02-14 |
| Luly Jay R. | director, officer: President and CEO | 2025-02-12 | F-InKind | 5.59 | 2025-02-14 |
| Luly Jay R. | director, officer: President and CEO | 2025-02-12 | P-Purchase | 5.69 | 2025-02-12 |
| Kieffer Tara Lynn | officer: Chief Product Strategy Officer | 2024-12-06 | S-Sale | 8.06 | 2024-12-10 |
| Luu Brendan | officer: Chief Business Officer | 2024-12-06 | S-Sale | 8.06 | 2024-12-10 |
| Rottinghaus Scott T. | officer: Chief Medical Officer | 2024-12-06 | S-Sale | 8.06 | 2024-12-10 |
| Or Yat Sun | officer: Chief Scientific Officer | 2024-12-06 | S-Sale | 8.06 | 2024-12-10 |
| MELLETT PAUL J | officer: Chief Fin. & Admin Officer | 2024-12-06 | S-Sale | 8.06 | 2024-12-10 |
| Luly Jay R. | director, officer: President and CEO | 2024-12-06 | S-Sale | 8.06 | 2024-12-10 |
| Luu Brendan | officer: Chief Business Officer | 2024-12-01 | F-InKind | 8.6 | 2024-12-03 |
| Kieffer Tara Lynn | officer: Chief Product Strategy Officer | 2024-12-01 | F-InKind | 8.6 | 2024-12-03 |
| Or Yat Sun | officer: Chief Scientific Officer | 2024-12-01 | F-InKind | 8.6 | 2024-12-03 |
| MELLETT PAUL J | officer: Chief Fin. & Admin Officer | 2024-12-01 | F-InKind | 8.6 | 2024-12-03 |
| Luly Jay R. | director, officer: President and CEO | 2024-12-01 | F-InKind | 8.6 | 2024-12-03 |
| Kowalsky Matthew Paul | officer: Chief Legal Officer | 2024-11-27 | A-Award | 8.83 | 2024-11-27 |